Abbott India informs about change in management

03 Feb 2025 Evaluate
With reference to earlier communication dated January 21, 2025, wherein the Company had informed that Kunal Chowdhury - Commercial Director - GI Businesses has been promoted to another affiliate of the company effective February 1, 2025. Accordingly, he has served his role as Commercial Director - GI Businesses with the company until January 31, 2025. Further to the above communication and pursuant to Regulation 30 read with Clause 7C of Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Abbott India has informed that it enclosed the letter received from Kunal Chowdhury.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

27829.85 131.70 (0.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×